KR19990065107A - Simultaneous Detection of Multiple Genes of Escherichia Coli O157: H7 Using Polymerase Chain Reaction - Google Patents

Simultaneous Detection of Multiple Genes of Escherichia Coli O157: H7 Using Polymerase Chain Reaction Download PDF

Info

Publication number
KR19990065107A
KR19990065107A KR1019980000220A KR19980000220A KR19990065107A KR 19990065107 A KR19990065107 A KR 19990065107A KR 1019980000220 A KR1019980000220 A KR 1019980000220A KR 19980000220 A KR19980000220 A KR 19980000220A KR 19990065107 A KR19990065107 A KR 19990065107A
Authority
KR
South Korea
Prior art keywords
coli
pcr
meat
polymerase chain
chain reaction
Prior art date
Application number
KR1019980000220A
Other languages
Korean (ko)
Other versions
KR100248909B1 (en
Inventor
정석찬
박용호
정병열
윤장원
김종염
조윤상
Original Assignee
김강권
대한민국(관리부서:농촌진흥청)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김강권, 대한민국(관리부서:농촌진흥청) filed Critical 김강권
Priority to KR1019980000220A priority Critical patent/KR100248909B1/en
Publication of KR19990065107A publication Critical patent/KR19990065107A/en
Application granted granted Critical
Publication of KR100248909B1 publication Critical patent/KR100248909B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Abstract

대장균 O157:H7감염증은 주로 축산식품을 통하여 사람에 감염하여 출혈성 장염으로 인해 심한 혈액성 설사를 일으키고 심한 경우 용혈성 요독 증후군 및 혈소판감소성 전색성자반병등으로 사망하기도 하는 식중독으로서 미국, 캐나다, 일본, 유럽 등 외국에서 많이 발생하여 그 피해가 크다.E. coli O157: H7 infection is a food poisoning that infects humans mainly through livestock foods, causing severe bloody diarrhea due to hemorrhagic enteritis, and in severe cases, hemolytic uremic syndrome and thrombocytopenic purpura. It is a lot of damage in Europe and other countries.

본 발명은 중합효소연쇄반응(PCR:polymerase chain reaction)법을 응용하여 병원성 대장균(O157:H7)이 가지고 있는 특이 유전자 4종(베로톡신 2종, 장벽 부착 병원인자, 효소 특이 유전자)을 검출할수 있는 세계 최초의 다종유전자 동시 검출 방법(multiplex-PCR)에 관한 발명이다. 이 검출법의 검출효율은 식육 1g당 1개-10개만이 있어도 검출이 가능하며, 검출시간도 1일-3일 이내에 가능할 뿐만 아니라 단 한번의 검사로 대장균 O157:H7 검출과 동시에 병원성관련 인자(베로톡신, 장벽부착병원인자)도 확인이 가능하여 매우 편리한 방법이다. 따라서 이 방법은 식육의 병원성 대장균 검사 뿐만아니라 동물의 분변 및 사람 식중독환자에도 응용이 가능하여 산업체에 활용될 가능성이 높으며, 안전 축산물 생산 및 국민의 공중보건 향상에 크게 기여할 것으로 판단된다.The present invention is capable of detecting four specific genes (two verotoxins, barrier-associated pathogens and enzyme-specific genes) of pathogenic E. coli (O157: H7) by applying a polymerase chain reaction (PCR) method. Invention of the world's first multiplex-PCR method. The detection efficiency of this method can be detected even if only 1-10 per 1g of meat is detected, and the detection time can be detected within 1 to 3 days, and the detection of Escherichia coli O157: H7 with a single test is performed. Toxin and barrier-associated pathogen) are also very convenient. Therefore, this method is applicable to industrial fecal and human food poisoning patients as well as pathogenic E. coli testing of meat, and is likely to be used in industry, and is expected to greatly contribute to the production of safe livestock products and public health.

Description

중합효소 연쇄반응을 이용한 대장균 O157:H7의 다종 유전자 동시검출방법Simultaneous Detection of Multiple Genes of Escherichia Coli O157: H7 Using Polymerase Chain Reaction

본 발명은 축산물에 중합효소연쇄반응(PCR) 기법을 응용하여 대장균(E. coli) O157:H7을 신속하고 정확하게 확인할 수 있는 다종 유전자 동시검출기법(Multiplex-PCR) 및 식육중 병원성대장균의 오염여부를 조기에 확인할 수 있는 방법에 관한 발명으로서 축산물의 안전성 확보와 국민건강증진을 제공하는데 그 목적이 있다.The present invention is to apply the polymerase chain reaction (PCR) technique to livestock products, and to determine whether E. coli O157: H7 can be identified quickly and accurately by multiple gene co-detection (Multiplex-PCR) and contamination of pathogenic E. coli in meat. The invention relates to a method of early confirmation of the purpose of ensuring the safety of livestock products and to provide public health.

병원성 대장균O157:H7 식중독은 1982년 미국에서 처음 발생된 이후에 북미, 유럽, 아시아, 아프리카등 전 세계적으로 발생하고 있으며, 출혈성 대장염, 용혈성요독증후군등에 의한 사망등으로 사람에 치명적이다. 따라서 축산식품의 안전한 생산 공급 측면에서 식육중 대장균O157:H7의 신속하고 정확한 검출기법 개발은 공중보건학적 측면에서 매우 중요시 되고 있다.Pathogenic E. coli O157: H7 Food poisoning has occurred worldwide in North America, Europe, Asia, and Africa since it first occurred in 1982 in the United States, and is fatal to humans due to hemorrhagic colitis and hemolytic uremic syndrome. Therefore, the development of rapid and accurate detection method of E. coli O157: H7 in meat in terms of the safe production and supply of livestock foods has become very important in public health.

대장균O157:H7은 장관세포에 부착과 상피세포를 파괴하는 장벽부착 병원인자를 지배하는 (attaching and effacing : eae A)를 가지며, 이 eae A 유전자는 대장균O157:H7균의 세포벽에 인티민(Intimin)의 생산을 지배하고, 이 인티민물질이 장벽의 부착과 상피세포의 파괴에 중요한 병원성 요인으로 작용한다. 또한 대장균O157:H7은 하나 또는 2가지의 베로톡신(slt Ⅰ, Ⅱ)을 산생하는 것으로 알려져 있어서 톡신이 신장조직내로 침투하여 용혈성요독증후군을 유발하는 것으로 알려져 있다. 또한 대장균O157:H7은 일반대장균과는 달리 β-D-글루쿠로니데이스(MUG) 활성을 띠지 않으므로 이 특이효소 유전자(uidA)를 이용하여 대장균O157:H7을 일반대장균과 구별할수 있다.Escherichia coli O157: H7 has an attaching and effacing (eae A) factor that attaches to the intestinal cells and destroys the epithelial cells, and this eae A gene is expressed on the cell wall of E. coli O157: H7. ), And this intiminant acts as an important pathogenic factor in the attachment of barriers and destruction of epithelial cells. In addition, Escherichia coli O157: H7 is known to produce one or two verotoxins (slt I and II), which is known to induce hemolytic uremic syndrome by infiltrating into kidney tissue. In addition, since E. coli O157: H7 does not have β-D-glucuronides (MUG) activity unlike ordinary E. coli, E. coli O157: H7 can be distinguished from general E. coli using this specific enzyme gene (uidA).

1980년대 대장균(O157:H7)의 분리방법이 개발되어 최종 확인방법으로서 널리 사용되어 왔으나 시간이 많이 소요된다는 단점이 있다. 또한 톡신검사법, 효소면역법, 유전자탐색법등이 있으나 절차가 번거롭고 시간이 많이 소요되는 단점이 있다. 최근 미국식품의약품청(FDA)에서 베로톡신 2종 및 글루쿠로니데이즈 효소등 3종 유전자를 동시 검출기법을 개발한바 있으나 실용화되지 못하고 있다.Separation method of Escherichia coli (O157: H7) was developed in the 1980s and has been widely used as a final confirmation method, but it has a disadvantage in that it takes much time. In addition, there are toxin test method, enzyme immunoassay method, gene search method, etc., but the procedure is cumbersome and time-consuming disadvantages. Recently, the US Food and Drug Administration (FDA) has developed a simultaneous detection method for three genes such as verotoxin and glucuronides enzyme, but it has not been put to practical use.

동물 및 사람의 분변 또는 식육으로부터 병원성 대장균(O157:H7)을 검출하는 데는 여러 가지 방법이 사용되어 왔다.Several methods have been used to detect pathogenic E. coli (O157: H7) from feces or meat from animals and humans.

첫째로는 표준방법으로서 시료를 증균배지에서 증균한 후 멕콩키 솔비톨한천배지(MacConkey sorbitol agar)에 배양하여 솔비톨 비분해균에 대하여 생화학적 특성 검사로 확인하고 분리균주를 항혈청을 이용하여 혈청학적으로 동정하는 방법이다. 대장균은 흔히 자연계나 분변중에 존재하는 장내세균으로 균체항원(O) 171종이상, 편모항원(H) 80종이상, 협막항원(K) 56종이상 등에 따라 종류가 9,000여종 이상이 알려져 있어 혈청학적 분석이 수월하지 않고, 또한 대부분이 병원성이 없는 세균이다. 따라서 균을 분리하고 확인하기 위해서는 여러 가지 생화학적 성상확인을 해야하며, 대장균O157:H7은 일반 대장균과는 다르게 솔비톨(sorbitol)을 발효시키지 않고, 글루쿠로니데이즈 효소(β-D-glucuronidase)활성을 띄지 않으며, 일반 대장균을 분리하는 온도인 44.5℃에서 자라지 않는 특성이 있으므로 이의 확인이 필요하므로 많은 노력과 시간이 소요된다. 따라서 대장균O157:H7은 기존의 진단법인 균분리 및 혈창학적 동정은 최종 확인까지 최소 7일 이상의 많은 시간과 노동력이 필요하며, 검출율이 낮다. 더구나 시료로부터 대장균O157:H7균이 분리 되더라도 대장균의 병원성 유무를 확인하기 위해서는 베로톡신 2종(slt Ⅰ 및 Ⅱ)의 확인과 장벽에 부착하여 병을 일으키는 병원인자(attaching and effacement: eae A)등의 확인에도 많은 시간이 소요된다.First, as a standard method, the samples were enriched in enrichment medium, and then cultured in MacConkey sorbitol agar to confirm the biochemical characterization of sorbitol non-degrading bacteria. How to identify. Escherichia coli is an intestinal bacterium that is commonly found in nature or feces. More than 9,000 kinds are known according to the presence of more than 171 cell antigens (O), 80 or more flagellar antigens (H), and 56 or more capsular antigens (K). The bacteria are not easy to analyze and most are nonpathogenic. Therefore, in order to isolate and identify bacteria, various biochemical properties must be confirmed.E. Coli O157: H7 does not ferment sorbitol, unlike ordinary E. coli, and glucuronidase enzyme (β-D-glucuronidase) activity It does not have a characteristic, because it does not grow at 44.5 ℃, which is the temperature for separating the common E. coli, it requires a lot of effort and time because it needs to be confirmed. Therefore, Escherichia coli O157: H7 requires a lot of time and labor for at least 7 days until the final confirmation of bacterial diagnosis and hemodynamic identification, and detection rate is low. In addition, even if E. coli O157: H7 is isolated from the sample, in order to confirm the pathogenicity of E. coli, it is necessary to identify two verotoxins (slt I and II) and attach them to the barrier and cause the disease (attaching and effacement: eae A) Checking takes a lot of time.

둘째로는 베로톡신 검출법으로서 대장균O157:H7은 하나 또는 2가지 shiga-like toxin(SLT, verotoxin)을 산생하는 것으로 알려져 있고, 베로톡신은 Vero 세포를 죽이므로 세포배양을 이용한 세포독성검사로 검출이 가능하다. 세포독성시험으로 분변이나 세균배양의 여과물에서 톡신을 검출할 수 있으나 검출율이 매우 낮고 많은 시간이 소요되며, 또한 베로톡신의 종류를 구분할 수 없으며, 베로톡신을 산생하는 대장균이 57종 이상이 알려져 있어 이들간에 구분이 곤란하다.Second, Escherichia coli O157: H7 is known to produce one or two shiga-like toxins (SLT, verotoxin). Verotoxin kills Vero cells, so it is not detected by cytotoxicity test using cell culture. It is possible. Cytotoxicity test can detect toxins in fecal or bacterial culture filtrate, but the detection rate is very low, it takes a lot of time, and also it is not possible to distinguish the type of verotoxin, and more than 57 species of E. coli producing verotoxin are produced. It is known and it is difficult to distinguish between them.

셋째로는 효소면역측정법(ELISA: Enzyme linked immunosorbent assay)으로서 O157항체를 이용한 각종 킷트가 이용되고 있으나 국내에는 아직 개발되어 있지 않은 실정이며, O157 항체는 살모넬라균 N 그룹(O30), 시트로박터균(Citrobacter freundii), 여시니아균(Yersinia enterocolitica O9), 이스케리키아 허마니(Escherichia hermanii)균과 교차응집반응을 일으키므로 특이성이 낮아 위양성반응이 많고, H7 항체검사를 별도로 수행하여야 하는 번거로움이 있으며, 이방법 역시 관련 병원성인자(slt Ⅰ, Ⅱ, eaeA) 확인은 불가능하다.Third, as an enzyme linked immunosorbent assay (ELISA), various kits using O157 antibodies have been used, but are not yet developed in Korea. O157 antibodies are Salmonella N group (O30) and Citrobacterium bacteria. (Citrobacter freundii), Yersinia enterocolitica O9, Escherichia hermanii (Escherichia hermanii) and cross-aggregation reactions due to the low specificity is a lot of false positives, H7 antibody test has to be performed separately This method also cannot identify related pathogenic factors (slt I, II, eaeA).

넷째로는 대장균O157:H7을 포함하여 베로톡신을 산생하는 모든 대장균을 특이적으로 탐지할 수 있는 유전자탐색(probe)방법으로서 베로톡신 Ⅰ과 Ⅱ 특이 probe가 개발된바 있으나 이 Probe로는 베로톡신을 산생하는 대장균 57종을 구분하는 것은 곤란하며, 중합효소연쇄반응(PCR:Polymerase Continuous Reaction)방법보다는 특이성이나 민감성이 낮다.Fourth, verotoxin I and II specific probes have been developed as a gene probe method that can specifically detect all E. coli producing verotoxin including E. coli O157: H7. It is difficult to distinguish 57 species of E. coli which are produced, and its specificity or sensitivity is lower than that of polymerase continuous reaction (PCR).

다섯째로는 중합효소연쇄반응(PCR)을 이용한 대장균의 베로톡신 Ⅰ 및 Ⅱ 유전자나 장벽부착병원인자를 검출하는데는 신속하고, 특이적이며 민감한 방법으로 알려져 왔다. 1995년 미국의 식품의약청(FDA)에서는 PCR기법을 이용하여 대장균O157:H7을 구분하는데 검사하는 클루쿠로니데이즈효소(glucuronidase) 유전자(uidA)와 베로톡신 Ⅰ 및 Ⅱ 등 3종의 유전자를 동시에 검출하는 방법을 개발하였다. 이 방법은 장벽에 부착하여 장융모의 탈락과 출혈성 대장염을 유발하는 장벽부착병원인자(attaching and effacement:eaeA)를 검출하지 못하는 단점이 있으며, 아울러 식육중에서 대장균O157:H7를 직접 검출하는 것은 아직 적용하지 못하고 있다.Fifth, it has been known to be a rapid, specific and sensitive method for the detection of E. coli Verotoxin I and II genes or barrier-associated pathogens by polymerase chain reaction (PCR). In 1995, the U.S. Food and Drug Administration (FDA) simultaneously detected three genes, glucuronidase enzyme (uidA) and verotoxin I and II, which are used to identify E. coli O157: H7 by PCR. Developed a method. This method has the disadvantage that it does not detect the attaching and effacement (eaeA), which is attached to the barrier and causes the fallout of enteric villi and hemorrhagic colitis, and the direct detection of E. coli O157: H7 in meat is still applied. I can't.

본 발명은 대장균O157:H7을 정확하게 동정하는데 있어서 상기한 기존의 여러 가지 단점들을 보완하고 식육중에서 직접 대장균O157:H7을 특이적으로 신속히 검출할수 있는 다종유전자 동시검출기법(multiplex-PCR)을 개발하였다.The present invention has developed a multiplex-PCR technique that complements the above-mentioned shortcomings in accurately identifying E. coli O157: H7 and can detect E. coli O157: H7 directly and rapidly in meat. .

즉, 본 발명은 multiplex-PCR을 이용하여 단 1회의 검사로써 대장균O157:H7의 4종 유전자(uidA, sltⅠ, slt Ⅱ, eaeA)를 동시에 확인하고 식육중 대장균O157:H7을 직접 검출하는 방법을 제공한다.That is, the present invention simultaneously identifies four genes (uidA, sltI, slt II, eaeA) of E. coli O157: H7 using only one test using multiplex-PCR, and directly detects E. coli O157: H7 in meat. to provide.

도 1은 세균염색체(genomic DNA) 분리 방법에 관한 모식도이다.1 is a schematic diagram of a method for separating bacterial chromosomes (genomic DNA).

도 2는 식육중 대장균 O157:H7의 염색체 분리 방법에 관한 모식도이다.Figure 2 is a schematic diagram of the chromosome separation method of E. coli O157: H7 in meat.

도 3은 중합효소연쇄반응(multiplex-PCR)을 이용한 대장균O157:H7 검출방법에 관한 모식도이다.3 is a schematic diagram of a method for detecting E. coli O157: H7 using a polymerase chain reaction (multiplex-PCR).

도 4는 중합효소연쇄반응(multiplex-PCR)을 이용하여 대장균O157:H7을 특이적으로 검출한 결과를 나타낸 전기영동 사진이다.Figure 4 is an electrophoresis picture showing the results of the specific detection of E. coli O157: H7 using a polymerase chain reaction (multiplex-PCR).

도 5는 식육중 대장균O157:H7의 검출 민감성을 조사한 결과를 나타낸 전기영동 사진이다.Figure 5 is an electrophoresis picture showing the results of the detection sensitivity of E. coli O157: H7 in meat.

본 발명을 상세히 설명하면 다음과 같다.The present invention is described in detail as follows.

대장균O157:H7을 신속하고 정확히 검출하기 위해서는 우선 특이 프라이머를 작성해야 하는데, 일반대장균과 병원성대장균 O157:H7을 구분할수 있는 글루쿠로니데이스(glucuronidase) 특이 효소유전자(uidA)와 이 질병의 용혈성요독증후군을 유발하는 유전자인 베로톡신 유전자 2종(slt Ⅰ 및 Ⅱ) 그리고 출혈성장염을 유발하는 장벽부착병원유전자(eaeA)등 4종의 유전자에 대한 특이 프라이머를 인공합성하여 표 1과 같이 나타냈다.In order to detect E. coli O157: H7 quickly and accurately, it is necessary to prepare specific primers.The glucuronidase specific enzyme gene (uidA), which can distinguish between E. coli and pathogenic E. coli O157: H7, and hemolytic uremic disease of the disease Specific primers for four genes, including two verotoxin genes (slt I and II), which cause the late syndrome, and barrier-associated pathogens (eaeA), which cause hemorrhagic infection, were artificially synthesized and shown in Table 1.

[표 1] 대장균O157:H7검출을 위한 특이 프라이머(primer)의 염기서열Table 1 Sequence of specific primers for detecting E. coli O157: H7

[식육중의 대장균의 분리][Isolation of Escherichia Coli in Meat]

식육중 대장균O157:H7의 분리하기 위하여 쇠고기 25g을 모디파이드이시액(modified EC broth:novobiocin 20ug/ml) 225ml에 분쇄한후 37℃, 24시간 증균배양한 다음 1차 증균 배양액 10ml를 mTSB배치 novobiocin(20ug/ml) 90ml에 접종하여 37℃, 24시간 증균배양하였다. 증균 배양액을 세픽심(Cefixime) 0.05ug/ml 및 텔루리트칼륨(Potassium tellulite) 2.5ug/ml가 첨가된 멕콩기솔비톨아가(MacConkey sorbitol agar) 및 플루오로컬트대장균배지(Fluorocult E. coli O157 medium)에 직접 또는 적절히 희석(102-103)한 다음 도말하여 37℃에서 24시간 배양하여 집락이 SMAC에서는 무색, Fluorocult배지에서 녹색인 집락에 대해 각 평판(Plate)당 5개 이상씩 MacConkey agar에 도말하여 24시간 배양하였다. 유당 분해균에 대해 O157항혈청을 이용한 응집반응을 실시하였다. 분리균의 생화학 성상검사는 TSI에서 A/A(노란색/노란색)의 형성균을 대상으로 인돌:Indol(+), MR(+), VP(-), 구연산:Citrate(-), 유레아제:Urease(-), 아라비노스:Arabinose(+), 라이신:Lysine(+) 시험으로 대장균임을 확인한 후 추정되는 분리주에 대해 MUG(-), KCN(-), 셀로비오스(Cellobiose) 분해능(-)등의 생화학적 검사 및 혈청학적검사(O항원 및 H항원)를 추가로 실시하였다.To isolate E. coli O157: H7 from meat, 25 g of beef was ground in 225 ml of modified EC broth: novobiocin 20ug / ml, followed by enrichment culture at 37 ° C for 24 hours, and then 10 ml of the primary enrichment medium was mTSB. 20ug / ml) was inoculated into 90ml and cultured at 37 ° C. for 24 hours. The enrichment broth was treated with MacConkey sorbitol agar and Fluorocult E. coli O157 medium supplemented with 0.05 ug / ml of Cefixime and 2.5 ug / ml of potassium tellulite. ) Or directly diluted appropriately (10 2 -10 3 ), then incubated for 24 hours at 37 ° C. For colonies that are colorless in SMAC and green in fluorocult medium, at least 5 MacConkey agar per plate. The plate was incubated for 24 hours. Agglutination of lactose-degrading bacteria with O157 antiserum was performed. Biochemical tests of isolated bacteria were performed on TSI forming A / A (yellow / yellow) indole: Indol (+), MR (+), VP (-), citric acid: Citrate (-), and urease: Urease (-), arabinose: Arabinose (+), lysine: Lysine (+) test confirmed E. coli, MUG (-), KCN (-), Cellobiose resolution (-) Biochemical and serological tests (O and H antigens) were further performed.

[대장균에 대한 베로톡신의 검사][Test of Verotoxin for Escherichia Coli]

대장균에 대한 베로톡신의 검사는 베로(Vero)세포주를 사용하여 일반적인 세포독성시험법으로 검사하였으며, 균을 트립티케이스소이액(trypticase soy broth) 20ml에 접종하여 37℃에서 20-24시간 진탕배양하고, 배양액을 7,000Xg에서 30분간 원심침전시켜 상청액을 0.45um 여과막(membrane filter)을 이용하여 여과한 후 여과액을 2배계단 희석하여 검사에 사용하였다. Vero 세포주는 5% 송아지 태아혈청, 항생제 젠타마이신(gentamicin:50ug/ml)이 들어있는 이엠이엠(EMEM:Eagle's minimun essential medium) 배지에서 37℃, 5% CO2의 조건으로 배양하여 실험에 이용하였다. 균배양 상층 여과액을 마이크로플레이트의 구멍(well)당 20μl 씩 넣어 37℃, 5% CO2배양기에서 3일간 배양하면서 매일 세포독성(cytopathic effects:CPE)를 관찰하였다.Verotoxin test for Escherichia coli was carried out by a general cytotoxicity test using a Vero cell line, and the bacteria were inoculated in 20 ml of trypticase soy broth and shaken at 37 ° C for 20-24 hours. The culture solution was centrifuged at 7,000Xg for 30 minutes, the supernatant was filtered using a 0.45um membrane filter, and the filtrate was diluted twice. Vero cell lines were cultured at 37 ° C. and 5% CO 2 in EMEM (Eagle's minimun essential medium) medium containing 5% calf fetal serum and antibiotic gentamicin (50ug / ml). . The culture supernatant filtrate was added to each 20μl per well of the microplate was incubated for 3 days in 37 ℃, 5% CO 2 incubator to observe the cytopathic effects (CPE) daily.

배양 3일후 세포를 50% 사멸(CD50)시키는 최종 희석배수를 결정하였다.A final dilution factor of 50% killing (CD 50 ) after 3 days of culture was determined.

본 발명에 사용한 균주는 미국 펜실베니아 주립대학교에서 분양받은 대장균O157:H7 15주와 덴마크의 국제 장내세균센터에서 분양받은 일반대장균 9주 및 Salmonella cholerasuis, S. dublin, Klebsiella pneumoniae, Clostridium perfringens, Yersinia enterocolitica, Edwardsiella tarda등 총 31종을 사용하였다.Strains used in the present invention were 15 strains of E. coli O157: H7, which were sold at Pennsylvania State University, and 9 strains of E. coli, Salmonella cholerasuis, S. dublin, Klebsiella pneumoniae, Clostridium perfringens, Yersinia enterocolitica, A total of 31 species, including Edwardsiella tarda, were used.

[세균으로 부터 염색체의 분리][Isolation of Chromosomes from Bacteria]

세균으로부터 염색체(genomic DNA)의 분리는 세틸트리메틸 암모늄 브로마이드(CTAB:cetyltrimethyl ammonium bromide)-디엔에이침전(DNA precipitation)방법에 의해 실시하였다(도 2). 즉, 세균을 LB 배지 10ml에 접종하여 하룻밤 동안 진탕 배양한 후, 배양액 1.5ml을 취하여 균체를 원심침전시키고 배지성분을 제거하였다.Separation of genomic DNA from bacteria was carried out by cetyltrimethyl ammonium bromide (CTAB) -DNA precipitation (Fig. 2). That is, the bacteria were inoculated in 10 ml of LB medium and shaken overnight, and then 1.5 ml of the culture solution was taken to centrifuge the cells to remove the media components.

침전균체에 TE buffer(10mM Tris-HCl, 1mM EDTA pH 8.0) 567㎕를 가하여 재부유한 다음, 10% SDS 30㎕와 단백분해효소(proteinage K) 20㎎/ml가 증류수에 용해된 3㎕를 가하여 37℃에서 1시간 처리로 세포막을 파괴하였다. 세포성분, LPS 및 단백질 성분을 제거하기 위하여 5M NaCl용액을 100㎕, CTAB/NaCl용액(10% CTAB in 0.7M NaCl) 80㎕를 가하여 65℃에서 10분간 반응한 다음, 동량의 페놀(phenol) : 크로로포름(chloroform) : 이소아밀알콜(isoamylalcohol) 25:24:1을 가하고 12,000rpm에서 10분간 원심분리하여 단백질 성분을 제거하였다. 염색체(DNA)를 함유하는 상청액은 새로운 시험관으로 옮겨 0.6배량의 이소프로판올(isopropanol)을 가하여 염색체를 침전하였다. 염색체 침전물은 70% 에탄올(ethanol)로 세척후 건조시킨 다음, TE buffer(RNase : 20㎍/ml)으로 부유시킨 후 염색체량 측정기(Pharmacia LKB)에서 염색체농도를 측정한 후 사용하였다.Resuspend by adding 567 μL of TE buffer (10 mM Tris-HCl, 1 mM EDTA pH 8.0) to the precipitate, and then 3 μl of 30 μl of 10% SDS and 20 mg / ml of proteinase K dissolved in distilled water. The cell membrane was destroyed by treatment at 37 ° C. for 1 hour. To remove cell components, LPS and protein components, 100 μl of 5M NaCl solution and 80 μl of CTAB / NaCl solution (10% CTAB in 0.7M NaCl) were added and reacted at 65 ° C. for 10 minutes, followed by the same amount of phenol. : Chloroform: Chloroform: Isoamylalcohol 25: 24: 1 was added and centrifuged at 12,000 rpm for 10 minutes to remove protein components. The supernatant containing the chromosome (DNA) was transferred to a new test tube and 0.6 times of isopropanol was added to precipitate the chromosome. The chromosome precipitate was washed with 70% ethanol and dried, suspended in TE buffer (RNase: 20 µg / ml), and used after measuring the chromosome concentration in a chromosome mass analyzer (Pharmacia LKB).

[쇠고기에서 대장균염색체의 분리][Isolation of Escherichia Coli Chromosome from Beef]

쇠고기내 존재하는 대장균의 염색체(genomic DNA) 분리는 상기의 세균분리 방법에서와 같이 식육 25g을 modified EC broth(novobiocin 20㎍/ml) 225ml에 분쇄하여 1차 증균배양한 다음에 배양액 10ml를 mTSB배지(novobiocin : 20㎍/ml) 90ml에 접종하여 2차 증균배양 후 가열반응(boiling)으로 염새체를 분리하였다(도 3).Separation of genomic DNA of E. coli present in beef was carried out by crushing 25 g of meat into 225 ml of modified EC broth (novobiocin 20 µg / ml) as in the above bacterial separation method, followed by primary enrichment culture, and then 10 ml of culture medium to mTSB medium. (novobiocin: 20 ㎍ / ml) was inoculated in 90ml after the secondary enrichment culture was isolated by the heating (boiling) (Fig. 3).

증균배양액 10ml를 12,000rpm에서 5분간 원심침전시키고 배지성분을 제거하고 침전균체에 TE buffer(10mM Tris-HCl, 1mM EDTA pH 8.0) 500㎕를 가하여 재부유한 다음 100℃에서 10분간 끓인후 원심 상청액을 분리하였다. 동량의 phenol : chloroform : isoamylalcohol(25:24:1)를 가하고 12,000rpm에서 5분간 원심분리하여 단백질 성분을 제거하였다. 염색체를 함유하는 상청액은 새로운 시험관으로 옮겨 0.6배량의 isopropanol을 가하여 염색체를 침전하였다. 침전물은 70% ethanol로 세척후 건조시킨 다음 TE buffer(pH8.0) 20ul로 부유시켜 사용하였다.Centrifuge the 10ml enrichment broth at 12,000rpm for 5 minutes, remove the media, resuspend with 500µl of TE buffer (10mM Tris-HCl, 1mM EDTA pH 8.0), and boil at 100 ℃ for 10 minutes, and then centrifuge supernatant. Was separated. The same amount of phenol: chloroform: isoamylalcohol (25: 24: 1) was added and centrifuged at 12,000 rpm for 5 minutes to remove protein components. The supernatant containing the chromosome was transferred to a new test tube and 0.6 times of isopropanol was added to precipitate the chromosome. The precipitate was washed with 70% ethanol, dried and suspended in 20 ul of TE buffer (pH 8.0).

[PCR에 의한 유전자의 증폭][Amplification of Gene by PCR]

Multiplex-PCR에서의 변성(denaturation), 가열(annealing), 확장(extension)의 조건을 결정하고자 각기 다른 온도와 시간으로 예비실험을 실시한 후 PCR의 일반원리를 사용하여 2.5mM MgCl2, 50mM KCl, 10mM Tris HCl(pH8.3), 0.2mM dNTPs (deoxynucleotide triphosphates), 50 pmole primers(uidA, slt Ⅰ, Ⅱ, eaeA)의 반응액과, 실험에 사용된 E. coli O157:H7 또는 장내세균으로 부터 분리한 염색체 약 10ul를 가하여 94℃에서 5분간 처리한 다음 Taq DNA polymerase 2.5 units를 가하여 최종 용액이 100ul되게한 후 PCR 증폭을 수행하였다. PCR cycle은 denaturation 94℃/1분, annealing 60℃/1분, 그리고 extension은 72℃/1분의 조건으로 PCR기기(GeneAmp, Perkin Elimer Co.)내에서 35회 반복하여 증폭을 수행하였으며, 최종 extension은 3분간 실시하였다. 이와같은 DNA 증폭이 끝난 후, 각 증폭시료 10㎕를 에티듐브로마이드(ethidium bromide)가 함유된 1.0% 아가로스(anarose)젤에서 100V, 1시간 동안 전기영동을 전개한 후, 자외선 조사하에서 특정유전자 증폭여부를 확인 및 사진촬영하였다(도 4).In order to determine the conditions of denaturation, annealing and extension in the Multiplex-PCR, preliminary experiments were conducted at different temperatures and times, and then 2.5mM MgCl 2 , 50mM KCl, From the reaction solution of 10 mM Tris HCl (pH8.3), 0.2 mM dNTPs (deoxynucleotide triphosphates), 50 pmole primers (uidA, slt I, II, eaeA) and E. coli O157: H7 or enterobacteriaceae used in the experiment About 10ul of the isolated chromosome was added and treated for 5 minutes at 94 ° C. Then, Taq DNA polymerase 2.5 units were added to make the final solution 100ul, followed by PCR amplification. PCR amplification was repeated 35 times in PCR equipment (GeneAmp, Perkin Elimer Co.) under conditions of 94 ° C / 1 min for denaturation, 60 ° C / 1 min for annealing, and 72 ° C / 1 min for extension. Extension was performed for 3 minutes. After the DNA amplification, 10 μl of each amplified sample was subjected to electrophoresis for 100 V for 1 hour in a 1.0% agarose gel containing ethidium bromide, followed by specific genes under ultraviolet irradiation. The amplification was confirmed and photographed (Figure 4).

[실시예 1 본 발명의 프라이머를 이용한 대장균O157:H7에 대한 특이성]Example 1 Specificity for Escherichia Coli O157: H7 using the Primer of the Present Invention

본 발명에서 창제한 4종의 프라이머(primers: uidA, slt Ⅰ, Ⅱ, eaeA)를 사용하여 Multiplex-PCR법으로 대장균O157:H7에 대한 특이성을 확인하기 위한 실험을 실시하였다. 대장균O157:H7 15종, 일반대장균 9종, 대장균이외의 장내세균 7종으로 부터 추출한 각 염색체를 사용하여 Multiplex-PCR법로 증폭시킨 후, 1.0% agarose 젤에서 전기영동을 전개하였다. 그 결과 대장균O157:H7 균주 모두에서 특이 효소유전자(uidA)인 252bp크기의 증폭산물을 나타내었으나 다른 균종에서는 이 효소 유전자의 증폭산물을 나타내지 않아 특이성이 인정되었다. 또한 장벽부착병원인자(eaeA)인 1087bp크기의 유전자 증폭산물이 대장균O157:H7 모든 균주에서 확인할수 있어서 병원성이 있는 균주임을 알수 있었다. 대장균O157:H7 균주에 따라서 베로톡신 유전자인 slt Ⅰ 348bp, slt Ⅱ 584bp를 하나 또는 2가지 모두를 가지고 있음을 확인할 수 있었으며 이 결과는 베록톡신 산생균주의 성상과 일치하였다(도 4). 이러한 결과로 Multiplex-PCR법은 대장균O157:H7을 신속하고 정확하게 확인할수 있을 뿐만아니라 이균과 관련한 병원인자의 확인이 가능하였다.Four primers (primers: uidA, slt I, II, eaeA) created in the present invention were used to confirm specificity for E. coli O157: H7 by Multiplex-PCR. Each chromosome extracted from 15 E. coli O157: H7, 9 general E. coli, and 7 non-E. Coli bacteria was amplified by Multiplex-PCR method, followed by electrophoresis on 1.0% agarose gel. As a result, all of the E. coli O157: H7 strains showed 252 bp amplification products, which were specific enzyme genes (uidA), but the other species did not show the amplification products of this enzyme gene. In addition, the 1087bp gene amplification product of the barrier-associated pathogen (eaeA) was confirmed in all strains of Escherichia coli O157: H7. According to the E. coli O157: H7 strain, one or both of the verotoxin genes slt I 348bp and slt II 584bp were confirmed, and the results were consistent with the properties of the belotoxin production strains (FIG. 4). As a result, the Multiplex-PCR method was able to identify E. coli O157: H7 quickly and accurately, as well as to identify pathogens related to the bacteria.

본 발명의 민감도를 조사하기 위하여 대장균O157:H7 균을 식육 g당 100개 에서 108개 까지 인공적으로 접종하여 Multiplex-PCR을 수행하였다. 그결과 1차 증균액에서는 식육 g당 104개 까지 검출이 가능하였으나 2차 증균액에서는 100개 까지 검출이 가능하였다(도 5). 이 결과는 식육중에서 1-10개 정도의 균까지도 검출할수 있는 매우 민감한 반응임을 알 수 있었다.In order to investigate the sensitivity of the present invention, Multiplex-PCR was performed by artificially inoculating Escherichia coli O157: H7 bacteria from 10 0 to 10 8 g per meat. As a result, up to 10 4 can be detected per g of meat in the first enrichment, but up to 10 0 can be detected in the second enrichment (Figure 5). This result is a very sensitive reaction that can detect up to 1-10 bacteria in the meat.

[실시예 2 본 발명과 베로세포독성시험의 비교검사]Example 2 Comparative test of the present invention and Vero cell toxicity test

대장균의 베로톡신 산생능과 본 발명을 이용한 베로톡신 유전자검출법간의 비교조사 결과 대장균O157:H7 13주 및 대장균 O111 1주에서 베로톡신을 산생함이 확인되었으며, 대장균O157:H7 2주 및 기타 일반대장균은 베로톡신을 산생하지 않는 것으로 나타나 베로세포독성시험과 Multiplex-PCR간에 완전히 일치하는 성적을 보였다(표 2). 이는 본 발명품이 베로세포독성시험을 대체할 수 있을 뿐만아니라 베로톡신 종류도 확인할 수 있는 방법임을 알수 있었다.Comparison between the veratoxin production of Escherichia coli and the verotoxin gene detection method using the present invention showed that verotoxin was produced in 13 strains of E. coli O157: H7 and 1 strain of E. coli O111, and 2 strains of E. coli O157: H7 and other common Escherichia coli. Did not produce verotoxin, which was in perfect agreement between the vero cytotoxicity test and Multiplex-PCR (Table 2). It was found that the present invention can not only replace the vero cytotoxicity test but also identify the verotoxin type.

[표 2] Multiplex-PCR법 베로세포독성시험 비교검사[Table 2] Comparative test of Vero cytotoxicity test of Multiplex-PCR method

[실시예 3 쇠고기에서 대장균O157:H7 의 검출]Example 3 Detection of Escherichia Coli O157: H7 in Beef

본 발명의 방법으로 쇠고기 40예를 직접 검사한 결과 베로톡신 Ⅰ 및 Ⅱ를 산생하는 대장균 4건이 검출되었으나, 이들 가검물에서 대장균O157:H7에서 특이적으로 인정되는 uidA 유전자와 장벽부착병원인자인 eaeA 유전자는 검출되지 않아 대장균O157:H7은 아님을 확인할 수 있었다. 또한 이들 재료로부터 표준분리방법으로 혈청형은 각각 O6, O112, O115, O139였고, 대장균O157:H7은 전혀 분리되지 않아 Multiplex-PCR방법과 표준분리방법의 결과는 일치하였다(표 3).As a result of direct examination of 40 cases of beef by the method of the present invention, four E. coli producing verotoxin I and II were detected, but the uidA gene and eaeA gene, which is a barrier-associated pathogen, were specifically recognized in E. coli O157: H7. Was not detected, and it was confirmed that E. coli O157: H7 was not. The serotypes were O6, O112, O115, and O139, respectively, and E. coli O157: H7 was not isolated at all, and the results of the Multiplex-PCR method and the standard separation method were consistent with each other (Table 3).

[표 3] Multiplex-PCR을 이용한 식육중 병원성 대장균 검출시험[Table 3] Detection of pathogenic E. coli in meat using Multiplex-PCR

이상의 실험결과에서 알수 있듯이 본 발명의 방법은 시료에서 대장균을 검출하는데 있어 1일-3일의 단시간에 검출이 가능할 뿐만 아니라 단 한번의 검사로 대장균 O157:H7의 신속하고 정확한 검출과 동시에 이균과 관련한 병원성 인자(베로톡신 2종, 장벽부착병원인자)도 확인이 가능하여 매우 편리한 방법으로서 식육은 물론 동물의 분변이나 식중독 환자의 분변등에도 적용이 가능하여 공중보건향상에 크게 기여할 것으로 기대된다.As can be seen from the above experimental results, the method of the present invention not only detects E. coli in a sample in a short time from 1 day to 3 days, but also enables rapid and accurate detection of E. coli O157: H7 in a single test. Pathogenic factors (2 verotoxins, barrier-associated pathogens) can also be identified, which is a very convenient method, and can be applied to not only meat but also feces of animals or food poisoning patients.

Claims (3)

대장균 O157:H7의 검출에 있어서, 프라이머인 uidA, slt Ⅰ, slt Ⅱ, eaeA 등 4종의 특이 효소유전자를 동시에 사용하는 것을 특징으로 하는 중합효소연쇄반응에 의한 대장균 O157:H7의 다종 유전자 동시검출방법.In detecting E. coli O157: H7, simultaneous detection of multiple genes of E. coli O157: H7 by polymerase chain reaction, characterized by simultaneous use of four specific enzyme genes such as primers uidA, slt I, slt II, and eaeA Way. 제 1항에 있어서,The method of claim 1, 프라이머는 다음과 같이 4종의 특이 효소유전자의 염기서열로 구성된 것을 특징으로 하는 중합효소연쇄반응에 의한 대장균 O157:H7의 다종 유전자 동시검출방법.Primer is a multi-gene simultaneous detection method of E. coli O157: H7 by the polymerase chain reaction, characterized in that consisting of the nucleotide sequence of four specific enzyme genes as follows. 제 1항에 있어서,The method of claim 1, 추출염색체(genomic DNA)를 효소 연속반응액에 4종의 프라이머(uidA, slt Ⅰ, slt Ⅱ, eaeA)와 함께 첨가하여 반응시킨 후 유전자를 변성시키고, 증폭효소를 첨가하여 유전자를 증폭하여 증폭된 유전자를 확인 및 판독하는 것을 특징으로 하는 다중중합효소연속반응을 이용한 대장균 O157:H7 다종 유전자 동시검출방법.The extracted chromosome (genomic DNA) was added to the enzyme continuous reaction solution with four kinds of primers (uidA, slt I, slt II, eaeA), and then denatured and amplified by amplifying the gene. E. coli O157: H7 multi-gene simultaneous detection method using multiple polymerase continuous reaction, characterized in that for identifying and reading the gene.
KR1019980000220A 1998-01-07 1998-01-07 Simultaneous detection of the gene of escherichia coli 0157:h7 from meats by multiplex-pcr KR100248909B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980000220A KR100248909B1 (en) 1998-01-07 1998-01-07 Simultaneous detection of the gene of escherichia coli 0157:h7 from meats by multiplex-pcr

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980000220A KR100248909B1 (en) 1998-01-07 1998-01-07 Simultaneous detection of the gene of escherichia coli 0157:h7 from meats by multiplex-pcr

Publications (2)

Publication Number Publication Date
KR19990065107A true KR19990065107A (en) 1999-08-05
KR100248909B1 KR100248909B1 (en) 2000-04-01

Family

ID=19531085

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980000220A KR100248909B1 (en) 1998-01-07 1998-01-07 Simultaneous detection of the gene of escherichia coli 0157:h7 from meats by multiplex-pcr

Country Status (1)

Country Link
KR (1) KR100248909B1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020089233A (en) * 2002-09-24 2002-11-29 최석호 The method of RT-PCR to detect viable bacteria by using ribonuclease treatment
KR20020090257A (en) * 2001-05-26 2002-12-02 주식회사 서린바이오사이언스 Multiplex pcr primers for detecting non-pathogenic e.coli, ehec, etec e.coli causing enteritis and o-157:h7, and method for performing multiplex pcr using the same
KR100408784B1 (en) * 2001-02-26 2003-12-06 삼성에버랜드 주식회사 A method and test kit for detecting pathogenic microorganism by multiplex-pcr
KR100457355B1 (en) * 2002-03-27 2004-11-16 삼성에버랜드 주식회사 Pcr primers for amplifying the gene of pathogenic microorganism, and method and test kit for detecting pathogenic microorganism by using the same
WO2006090945A1 (en) * 2005-02-28 2006-08-31 Samsung Everland Inc. Primer for detecting food poisoning and method for rapid detection of food born pathogene

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101156719B1 (en) 2011-10-21 2012-06-27 대한민국 Method of detecting enterovirulent escherichia coli and detection set

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100408784B1 (en) * 2001-02-26 2003-12-06 삼성에버랜드 주식회사 A method and test kit for detecting pathogenic microorganism by multiplex-pcr
KR20020090257A (en) * 2001-05-26 2002-12-02 주식회사 서린바이오사이언스 Multiplex pcr primers for detecting non-pathogenic e.coli, ehec, etec e.coli causing enteritis and o-157:h7, and method for performing multiplex pcr using the same
KR100457355B1 (en) * 2002-03-27 2004-11-16 삼성에버랜드 주식회사 Pcr primers for amplifying the gene of pathogenic microorganism, and method and test kit for detecting pathogenic microorganism by using the same
KR20020089233A (en) * 2002-09-24 2002-11-29 최석호 The method of RT-PCR to detect viable bacteria by using ribonuclease treatment
WO2006090945A1 (en) * 2005-02-28 2006-08-31 Samsung Everland Inc. Primer for detecting food poisoning and method for rapid detection of food born pathogene

Also Published As

Publication number Publication date
KR100248909B1 (en) 2000-04-01

Similar Documents

Publication Publication Date Title
Yang et al. Magnetic nano-beads based separation combined with propidium monoazide treatment and multiplex PCR assay for simultaneous detection of viable Salmonella Typhimurium, Escherichia coli O157: H7 and Listeria monocytogenes in food products
Stone et al. Detection of Salmonella serovars from clinical samples by enrichment broth cultivation-PCR procedure
Chiu et al. Rapid identification of Salmonella serovars in feces by specific detection of virulence genes, invA and spvC, by an enrichment broth culture-multiplex PCR combination assay
Kwang et al. Use of the polymerase chain reaction for Salmonella detection
Gannon et al. Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction
Okada et al. A rapid, simple, and sensitive loop-mediated isothermal amplification method to detect toxigenic Vibrio cholerae in rectal swab samples
WO1998020148A1 (en) Method for detection of pathogens in food
Ranjbar et al. Visual detection of Enterohemorrhagic Escherichia coli O157: H7 using loop-mediated isothermal amplification
Saito et al. Detection of Clostridium perfringens enterotoxin gene by the polymerase chain reaction amplification procedure
Paton et al. Methods for detection of STEC in humans: an overview
Mousavi et al. Simultaneous detection of Escherichia coli O157: H7, toxigenic Vibrio cholerae, and Salmonella typhimurium by multiplex PCR
Fach et al. Comparison of different PCR tests for detecting Shiga toxin-producing Escherichia coli O157 and development of an ELISA-PCR assay for specific identification of the bacteria
KR100248909B1 (en) Simultaneous detection of the gene of escherichia coli 0157:h7 from meats by multiplex-pcr
Adi et al. Multiplex quantification of Escherichia coli, Salmonella typhi and Vibrio cholera with three DNA targets in single reaction assay
Rich et al. Identification of human enterovirulent Escherichia coli strains by multiplex PCR
Shankar et al. Multiplex PCR assay for simultaneous detection and differentiation of Entamoeba histolytica, Giardia lamblia, and Salmonella spp. in the municipality-supplied drinking water
Wang Nucleic acid-based rapid methods for the detection of foodborne pathogens
Tsai et al. Detection of viable enterohemorrhagic Escherichia coli O157 using the combination of immunomagnetic separation with the reverse transcription multiplex TaqMan PCR system in food and stool samples
Welinder-Olsson et al. Improved microbiological techniques using the polymerase chain reaction and pulsed-field gel electrophoresis for diagnosis and follow-up of enterohaemorrhagic Escherichia coli infection
Farahmandfar et al. Comparison of two methods for detection of E. coli O157H7 in unpasteurized milk
US20010008887A1 (en) Method for detection of pathogens in food
Hara-Kudo et al. Surveillance of shiga toxin–producing Escherichia coli in beef with effective procedures, independent of serotype
Miyagi et al. An improved method for detecting faecal Vibrio cholerae by PCR of the toxin A gene
US6291168B1 (en) Nucleic acid sequences diagnostic for pathogenic E.coli O157:H7, methods of identification and kit therefore
US20050130155A1 (en) Primers for the detection and identification of bacterial indicator groups and virulene factors

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
EXPY Expiration of term